Easy: No special equipment needed, visual interpretation.
Rapid: Quick sampling by fingertip blood, in 10mins.
Accurate: Results with IgG and IgM respectively, validated with PCR and CT.
Application: Security test with symptoms, mild symptoms, also for testing people without symptoms but with close contact with infected cases
This kit is a rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies specific to SARS-CoV-2 (2019-nCoV) in human whole blood, serum or plasma as an aid in the scientific research of primary and secondary SARS-CoV-2 (2019-nCoV) infections.
This kit applies the GICA(Gold Immunochromatography) method for the detection of IgG and IgM specific to SARS-CoV-2 (2019-nCoV) in human whole blood, serum, or plasma. It consists of two test lines, an IgG line and an IgM line, and a control line. The anti-human IgG mouse monoclonal is pre-coated in IgG test line region while the anti-human IgM mouse monoclonal is pre-coated in IgM test line region. And the antimouse IgG goat polyclonal is pre-coated in the control line region.
During testing, the sample reacts with SARS-CoV-2 (2019-nCoV) antigen-coated particles in the test cassette. The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgG in IgG test line region. If the sample contains IgG antibodies to SARS-CoV-2 (2019-nCoV), a colored line will appear in IgG test line region. In the same way, if the sample contains IgM antibodies to SARS-CoV-2 (2019-nCoV), a colored line will appear in IgM test line region. And if the tested sample does not contain antibodies specific to SARS-CoV-2 (2019-nCoV), no colored line will appear in either of the two test line regions, which indicates a negative result.
To serve as a procedural control, a colored line will always appear in the control line region, indicating that the proper volume of sample has been added and membrane wicking has occurred.
1) When the bilirubin concentration is ≤ 250 μmol/L, the hemoglobin content is ≤ 9 g/L, the triglyceride content is ≤ 15 mmol/L, the rheumatoid factor content is ≤ 80 IU/mL, and the antinuclear antibody (ANA) titer is ≤ 1: 240, anti-mitochondrial antibody (AMA) ≤ 80 U/mL, mouse IgG content ≤ 1000 μg/mL, will not interfere with the detection results of this product.
2) Histamine hydrochloride, alpha-interferon, zanamivir, ribavirin, oseltamivir, peramivir, lopinavir, ritonavir, abidol, levofloxacin, azithromycin, Ceftriaxone, meropenem, and tobramycin have been validated to have no effect on the test results of this product.
5. Hook effect: Within the titer range of positive samples of the new coronavirus antibody, the test result of this product does not show a hook effect.
The test results of this product are not affected by the disrupted new coronavirus-specific IgM antibodies.